Global Ankylosing Spondylitis Drug Market Growth (Status and Outlook) 2022-2028
- LP 4874270
- 103 Pages
- February 2022
- Medical Devices
The United States Ankylosing Spondylitis Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ankylosing Spondylitis Drug market, reaching US$ million by the year 2028. As for the Europe Ankylosing Spondylitis Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ankylosing Spondylitis Drug players cover Amgen, Wyeth, Takeda, and Centocor, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ankylosing Spondylitis Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ankylosing Spondylitis Drug Market Size 2017-2028
2.1.2 Ankylosing Spondylitis Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Ankylosing Spondylitis Drug Segment by Type
2.2.1 Cimzia
2.2.2 Enbrel
2.2.3 Humira
2.2.4 Remicade
2.2.5 Simponi
2.2.6 Others
2.3 Ankylosing Spondylitis Drug Market Size by Type
2.3.1 Ankylosing Spondylitis Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Ankylosing Spondylitis Drug Market Size Market Share by Type (2017-2022)
2.4 Ankylosing Spondylitis Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Ankylosing Spondylitis Drug Market Size by Application
2.5.1 Ankylosing Spondylitis Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Ankylosing Spondylitis Drug Market Size Market Share by Application (2017-2022)
3 Ankylosing Spondylitis Drug Market Size by Player
3.1 Ankylosing Spondylitis Drug Market Size Market Share by Players
3.1.1 Global Ankylosing Spondylitis Drug Revenue by Players (2020-2022)
3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2020-2022)
3.2 Global Ankylosing Spondylitis Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Ankylosing Spondylitis Drug by Regions
4.1 Ankylosing Spondylitis Drug Market Size by Regions (2017-2022)
4.2 Americas Ankylosing Spondylitis Drug Market Size Growth (2017-2022)
4.3 APAC Ankylosing Spondylitis Drug Market Size Growth (2017-2022)
4.4 Europe Ankylosing Spondylitis Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Ankylosing Spondylitis Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Ankylosing Spondylitis Drug Market Size by Country (2017-2022)
5.2 Americas Ankylosing Spondylitis Drug Market Size by Type (2017-2022)
5.3 Americas Ankylosing Spondylitis Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ankylosing Spondylitis Drug Market Size by Region (2017-2022)
6.2 APAC Ankylosing Spondylitis Drug Market Size by Type (2017-2022)
6.3 APAC Ankylosing Spondylitis Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Ankylosing Spondylitis Drug by Country (2017-2022)
7.2 Europe Ankylosing Spondylitis Drug Market Size by Type (2017-2022)
7.3 Europe Ankylosing Spondylitis Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ankylosing Spondylitis Drug by Region (2017-2022)
8.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Ankylosing Spondylitis Drug Market Forecast
10.1 Global Ankylosing Spondylitis Drug Forecast by Regions (2023-2028)
10.1.1 Global Ankylosing Spondylitis Drug Forecast by Regions (2023-2028)
10.1.2 Americas Ankylosing Spondylitis Drug Forecast
10.1.3 APAC Ankylosing Spondylitis Drug Forecast
10.1.4 Europe Ankylosing Spondylitis Drug Forecast
10.1.5 Middle East & Africa Ankylosing Spondylitis Drug Forecast
10.2 Americas Ankylosing Spondylitis Drug Forecast by Country (2023-2028)
10.2.1 United States Ankylosing Spondylitis Drug Market Forecast
10.2.2 Canada Ankylosing Spondylitis Drug Market Forecast
10.2.3 Mexico Ankylosing Spondylitis Drug Market Forecast
10.2.4 Brazil Ankylosing Spondylitis Drug Market Forecast
10.3 APAC Ankylosing Spondylitis Drug Forecast by Region (2023-2028)
10.3.1 China Ankylosing Spondylitis Drug Market Forecast
10.3.2 Japan Ankylosing Spondylitis Drug Market Forecast
10.3.3 Korea Ankylosing Spondylitis Drug Market Forecast
10.3.4 Southeast Asia Ankylosing Spondylitis Drug Market Forecast
10.3.5 India Ankylosing Spondylitis Drug Market Forecast
10.3.6 Australia Ankylosing Spondylitis Drug Market Forecast
10.4 Europe Ankylosing Spondylitis Drug Forecast by Country (2023-2028)
10.4.1 Germany Ankylosing Spondylitis Drug Market Forecast
10.4.2 France Ankylosing Spondylitis Drug Market Forecast
10.4.3 UK Ankylosing Spondylitis Drug Market Forecast
10.4.4 Italy Ankylosing Spondylitis Drug Market Forecast
10.4.5 Russia Ankylosing Spondylitis Drug Market Forecast
10.5 Middle East & Africa Ankylosing Spondylitis Drug Forecast by Region (2023-2028)
10.5.1 Egypt Ankylosing Spondylitis Drug Market Forecast
10.5.2 South Africa Ankylosing Spondylitis Drug Market Forecast
10.5.3 Israel Ankylosing Spondylitis Drug Market Forecast
10.5.4 Turkey Ankylosing Spondylitis Drug Market Forecast
10.5.5 GCC Countries Ankylosing Spondylitis Drug Market Forecast
10.6 Global Ankylosing Spondylitis Drug Forecast by Type (2023-2028)
10.7 Global Ankylosing Spondylitis Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Ankylosing Spondylitis Drug Product Offered
11.1.3 Amgen Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Wyeth
11.2.1 Wyeth Company Information
11.2.2 Wyeth Ankylosing Spondylitis Drug Product Offered
11.2.3 Wyeth Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Wyeth Main Business Overview
11.2.5 Wyeth Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Ankylosing Spondylitis Drug Product Offered
11.3.3 Takeda Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Centocor
11.4.1 Centocor Company Information
11.4.2 Centocor Ankylosing Spondylitis Drug Product Offered
11.4.3 Centocor Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Centocor Main Business Overview
11.4.5 Centocor Latest Developments
11.5 Schering-Plough
11.5.1 Schering-Plough Company Information
11.5.2 Schering-Plough Ankylosing Spondylitis Drug Product Offered
11.5.3 Schering-Plough Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Schering-Plough Main Business Overview
11.5.5 Schering-Plough Latest Developments
11.6 Mitsubishi Tanabe
11.6.1 Mitsubishi Tanabe Company Information
11.6.2 Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Offered
11.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Mitsubishi Tanabe Main Business Overview
11.6.5 Mitsubishi Tanabe Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Ankylosing Spondylitis Drug Product Offered
11.7.3 Abbott Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Eisai
11.8.1 Eisai Company Information
11.8.2 Eisai Ankylosing Spondylitis Drug Product Offered
11.8.3 Eisai Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Eisai Main Business Overview
11.8.5 Eisai Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Ankylosing Spondylitis Drug Product Offered
11.9.3 Pfizer Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Information
11.10.2 Johnson & Johnson Ankylosing Spondylitis Drug Product Offered
11.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Johnson & Johnson Main Business Overview
11.10.5 Johnson & Johnson Latest Developments
12 Research Findings and Conclusion
Table 1. Ankylosing Spondylitis Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Cimzia
Table 3. Major Players of Enbrel
Table 4. Major Players of Humira
Table 5. Major Players of Remicade
Table 6. Major Players of Simponi
Table 7. Major Players of Others
Table 8. Ankylosing Spondylitis Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Ankylosing Spondylitis Drug Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Ankylosing Spondylitis Drug Market Size Market Share by Type (2017-2022)
Table 11. Ankylosing Spondylitis Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Ankylosing Spondylitis Drug Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Ankylosing Spondylitis Drug Market Size Market Share by Application (2017-2022)
Table 14. Global Ankylosing Spondylitis Drug Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Ankylosing Spondylitis Drug Revenue Market Share by Player (2020-2022)
Table 16. Ankylosing Spondylitis Drug Key Players Head office and Products Offered
Table 17. Ankylosing Spondylitis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Ankylosing Spondylitis Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Ankylosing Spondylitis Drug Market Size Market Share by Regions (2017-2022)
Table 22. Americas Ankylosing Spondylitis Drug Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Ankylosing Spondylitis Drug Market Size Market Share by Country (2017-2022)
Table 24. Americas Ankylosing Spondylitis Drug Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Ankylosing Spondylitis Drug Market Size Market Share by Type (2017-2022)
Table 26. Americas Ankylosing Spondylitis Drug Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Ankylosing Spondylitis Drug Market Size Market Share by Application (2017-2022)
Table 28. APAC Ankylosing Spondylitis Drug Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Ankylosing Spondylitis Drug Market Size Market Share by Region (2017-2022)
Table 30. APAC Ankylosing Spondylitis Drug Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Ankylosing Spondylitis Drug Market Size Market Share by Type (2017-2022)
Table 32. APAC Ankylosing Spondylitis Drug Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Ankylosing Spondylitis Drug Market Size Market Share by Application (2017-2022)
Table 34. Europe Ankylosing Spondylitis Drug Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Ankylosing Spondylitis Drug Market Size Market Share by Country (2017-2022)
Table 36. Europe Ankylosing Spondylitis Drug Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Ankylosing Spondylitis Drug Market Size Market Share by Type (2017-2022)
Table 38. Europe Ankylosing Spondylitis Drug Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Ankylosing Spondylitis Drug Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Ankylosing Spondylitis Drug Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Ankylosing Spondylitis Drug Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Ankylosing Spondylitis Drug Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Ankylosing Spondylitis Drug
Table 47. Key Market Challenges & Risks of Ankylosing Spondylitis Drug
Table 48. Key Industry Trends of Ankylosing Spondylitis Drug
Table 49. Global Ankylosing Spondylitis Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Ankylosing Spondylitis Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Ankylosing Spondylitis Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Ankylosing Spondylitis Drug Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Ankylosing Spondylitis Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Ankylosing Spondylitis Drug Market Size Market Share Forecast by Application (2023-2028)
Table 55. Amgen Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 56. Amgen Ankylosing Spondylitis Drug Product Offered
Table 57. Amgen Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Amgen Main Business
Table 59. Amgen Latest Developments
Table 60. Wyeth Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 61. Wyeth Ankylosing Spondylitis Drug Product Offered
Table 62. Wyeth Main Business
Table 63. Wyeth Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Wyeth Latest Developments
Table 65. Takeda Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 66. Takeda Ankylosing Spondylitis Drug Product Offered
Table 67. Takeda Main Business
Table 68. Takeda Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Takeda Latest Developments
Table 70. Centocor Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 71. Centocor Ankylosing Spondylitis Drug Product Offered
Table 72. Centocor Main Business
Table 73. Centocor Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Centocor Latest Developments
Table 75. Schering-Plough Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 76. Schering-Plough Ankylosing Spondylitis Drug Product Offered
Table 77. Schering-Plough Main Business
Table 78. Schering-Plough Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Schering-Plough Latest Developments
Table 80. Mitsubishi Tanabe Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 81. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Offered
Table 82. Mitsubishi Tanabe Main Business
Table 83. Mitsubishi Tanabe Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Mitsubishi Tanabe Latest Developments
Table 85. Abbott Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 86. Abbott Ankylosing Spondylitis Drug Product Offered
Table 87. Abbott Main Business
Table 88. Abbott Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Abbott Latest Developments
Table 90. Eisai Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 91. Eisai Ankylosing Spondylitis Drug Product Offered
Table 92. Eisai Main Business
Table 93. Eisai Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Eisai Latest Developments
Table 95. Pfizer Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 96. Pfizer Ankylosing Spondylitis Drug Product Offered
Table 97. Pfizer Main Business
Table 98. Pfizer Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Pfizer Latest Developments
Table 100. Johnson & Johnson Details, Company Type, Ankylosing Spondylitis Drug Area Served and Its Competitors
Table 101. Johnson & Johnson Ankylosing Spondylitis Drug Product Offered
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Ankylosing Spondylitis Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Ankylosing Spondylitis Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ankylosing Spondylitis Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Ankylosing Spondylitis Drug Market Size Market Share by Type in 2021
Figure 7. Ankylosing Spondylitis Drug in Hospitals
Figure 8. Global Ankylosing Spondylitis Drug Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Ankylosing Spondylitis Drug in Clinics
Figure 10. Global Ankylosing Spondylitis Drug Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Global Ankylosing Spondylitis Drug Market Size Market Share by Application in 2021
Figure 12. Global Ankylosing Spondylitis Drug Revenue Market Share by Player in 2021
Figure 13. Global Ankylosing Spondylitis Drug Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Ankylosing Spondylitis Drug Market Size 2017-2022 ($ Millions)
Figure 15. APAC Ankylosing Spondylitis Drug Market Size 2017-2022 ($ Millions)
Figure 16. Europe Ankylosing Spondylitis Drug Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Ankylosing Spondylitis Drug Market Size 2017-2022 ($ Millions)
Figure 18. Americas Ankylosing Spondylitis Drug Value Market Share by Country in 2021
Figure 19. Americas Ankylosing Spondylitis Drug Consumption Market Share by Type in 2021
Figure 20. Americas Ankylosing Spondylitis Drug Market Size Market Share by Application in 2021
Figure 21. United States Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Ankylosing Spondylitis Drug Market Size Market Share by Region in 2021
Figure 26. APAC Ankylosing Spondylitis Drug Market Size Market Share by Application in 2021
Figure 27. China Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Ankylosing Spondylitis Drug Market Size Market Share by Country in 2021
Figure 34. Europe Ankylosing Spondylitis Drug Market Size Market Share by Type in 2021
Figure 35. Europe Ankylosing Spondylitis Drug Market Size Market Share by Application in 2021
Figure 36. Germany Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Ankylosing Spondylitis Drug Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Ankylosing Spondylitis Drug Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Ankylosing Spondylitis Drug Market Size Market Share by Application in 2021
Figure 44. Egypt Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Ankylosing Spondylitis Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 50. APAC Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 51. Europe Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 53. United States Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 54. Canada Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 57. China Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 58. Japan Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 59. Korea Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 61. India Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 62. Australia Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 63. Germany Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 64. France Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 65. UK Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 66. Italy Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 67. Russia Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 68. Spain Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 71. Israel Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Ankylosing Spondylitis Drug Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
